GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
| Revenue (Most Recent Fiscal Year) | $40.10B |
| Net Income (Most Recent Fiscal Year) | $3.29B |
| PE Ratio (Current Year Earnings Estimate) | 10.85 |
| PE Ratio (Trailing 12 Months) | 11.05 |
| PEG Ratio (Long Term Growth Estimate) | 1.33 |
| Price to Sales Ratio (Trailing 12 Months) | 2.36 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.69 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.78 |
| Pre-Tax Margin (Trailing 12 Months) | 21.97% |
| Net Margin (Trailing 12 Months) | 17.16% |
| Return on Equity (Trailing 12 Months) | 48.64% |
| Return on Assets (Trailing 12 Months) | 11.50% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.84 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.55 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.95 |
| Inventory Turnover (Trailing 12 Months) | 1.49 |
| Book Value per Share (Most Recent Fiscal Quarter) | $8.07 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.48 |
| Earnings per Share (Most Recent Fiscal Year) | $4.05 |
| Diluted Earnings per Share (Trailing 12 Months) | $3.54 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Common Shares Outstanding | 2.03B |
| Free Float | 1.83B |
| Market Capitalization | $99.43B |
| Average Volume (Last 20 Days) | 4.27M |
| Beta (Past 60 Months) | 0.45 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 10.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 15.74% |
| Annual Dividend (Based on Last Quarter) | $1.64 |
| Dividend Yield (Based on Last Quarter) | 3.35% |